These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 8438450)

  • 1. Rapamycin treatment prevents and/or erases sensitization and abrogates accelerated rejection of vascularized organ allografts.
    Schmidbauer G; Hancock WW; Wasowska BA; Sablinski T; Kupiec-Weglinski JW
    Transplant Proc; 1993 Feb; 25(1 Pt 1):712-3. PubMed ID: 8438450
    [No Abstract]   [Full Text] [Related]  

  • 2. Rapamycin abrogates accelerated rejection in sensitized rats by selectively suppressing intragraft cell activation, adhesion/binding properties, and modulating serum alloantibody responses.
    Schmidbauer G; Hancock WW; Wasowska B; Binder J; Padberg W; Kupiec-Weglinski JW
    Transplant Proc; 1995 Feb; 27(1):427-9. PubMed ID: 7879048
    [No Abstract]   [Full Text] [Related]  

  • 3. Endocardial mononuclear cell infiltrates (Quilty effect) in heterotopic cardiac allografts in rapamycin-treated rats.
    Mohacsi PJ; Joshi A; Wang J; Morris RE; Billingham ME
    Transplant Proc; 1994 Dec; 26(6):3255-9. PubMed ID: 7998133
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy and mechanism of action of rapamycin in presensitized recipients of experimental allografts.
    Chen H; Wu J; Xu D; Luo H; Daloze P
    Transplant Proc; 1992 Oct; 24(5):1669-70. PubMed ID: 1412790
    [No Abstract]   [Full Text] [Related]  

  • 5. Rapamycin reverses acute heart, kidney, and pancreas allograft rejection and prevents accelerated heart allograft rejection in the rat.
    Chen H; Wu J; Xu D; Luo H; Daloze P
    Transplant Proc; 1993 Feb; 25(1 Pt 1):719-20. PubMed ID: 8438454
    [No Abstract]   [Full Text] [Related]  

  • 6. Cytokine and alloantibody networks in long-term cardiac allografts in rapamycin-treated sensitized rat recipients.
    Wasowska B; Wieder KJ; Hancock WW; Berse B; Binder J; Strom TB; Kupiec-Weglinski JW
    Transplant Proc; 1995 Feb; 27(1):423-6. PubMed ID: 7879047
    [No Abstract]   [Full Text] [Related]  

  • 7. Rapamycin's long-term effects on humoral and cellular immune responses in the rat.
    Daloze P; Chen H; Luo H; Xu D; Shan X; Wu J
    Transplant Proc; 1993 Feb; 25(1 Pt 1):721-2. PubMed ID: 8438456
    [No Abstract]   [Full Text] [Related]  

  • 8. In vivo use of rapamycin suppresses neither IL-2 production nor IL-2 receptor expression in rat transplant model.
    Hamashima T; Yoshimura N; Ohsaka Y; Oka T; Stepkowski SM; Kahan BD
    Transplant Proc; 1993 Feb; 25(1 Pt 1):723-4. PubMed ID: 8438457
    [No Abstract]   [Full Text] [Related]  

  • 9. Cytokine and alloantibody networks in long term cardiac allografts in rat recipients treated with rapamycin.
    Wasowska B; Wieder KJ; Hancock WW; Zheng XX; Berse B; Binder J; Strom TB; Kupiec-Weglinski JW
    J Immunol; 1996 Jan; 156(1):395-404. PubMed ID: 8598490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donor pretreatment with methylprednisolone synergistically prolongs survival of cardiac allografts in sensitized rat recipients conditioned with rapamycin.
    Schmidbauer G; Homeyer A; Bohle RM; Grimm H; Binder J; Kupiec-Weglinski JW
    Transplant Proc; 1997; 29(1-2):607-8. PubMed ID: 9123151
    [No Abstract]   [Full Text] [Related]  

  • 11. Different mechanisms of rejection of organ and cell allografts.
    Olszewski WL; Jasklowska-Englisz M; Lukomska B
    Transplant Proc; 1996 Dec; 28(6):3444-6. PubMed ID: 8962343
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term in vivo effects of rapamycin on humoral and cellular immune responses in the rat.
    Chen H; Luo H; Daloze P; Xu D; Shan X; St-Louis G; Wu J
    Immunobiology; 1993 Jul; 188(3):303-15. PubMed ID: 8225391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction between rapamycin and pretransplant blood transfusions in rat heterotopic heart transplantation.
    Tucker MJ; Duplan J; Li X; Garcia B; Wijsman J; Stiller C; McKenzie FN
    Transplant Proc; 1993 Feb; 25(1 Pt 1):725-6. PubMed ID: 8438458
    [No Abstract]   [Full Text] [Related]  

  • 14. Effective suppression of brequinar sodium on accelerated allograft rejection in presensitized recipients.
    Nozaki S; Ito T; Kamiike W; Uchikoshi F; Ito A; Kuhara A; Nakata S; Shirakura R; Miyata M; Matsuda H
    Transplant Proc; 1995 Feb; 27(1):451-2. PubMed ID: 7879059
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardiac graft rejection in hypersensitized recipients: prevention of antibody response and graft rejection using brequinar sodium.
    Yasunaga C; Cramer DV; Chapman FA; Wang HK; Barnett M; Wu GD; Makowka L
    Transplant Proc; 1993 Jun; 25(3 Suppl 2):65-6. PubMed ID: 8516948
    [No Abstract]   [Full Text] [Related]  

  • 16. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.
    Shimizu H; Takahashi M; Kaneko T; Murakami T; Hakamata Y; Kudou S; Kishi T; Fukuchi K; Iwanami S; Kuriyama K; Yasue T; Enosawa S; Matsumoto K; Takeyoshi I; Morishita Y; Kobayashi E
    Circulation; 2005 Jan; 111(2):222-9. PubMed ID: 15642767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular basis of immunologic tolerance following total bowel transplantation in rats. II. Dominant role of suppressor T cells in adoptive transfer of acquired tolerance to vascularized allografts.
    Masaki Y; Oohara T; Shinomiya T; Kimura H
    Transplant Proc; 1995 Apr; 27(2):1589-92. PubMed ID: 7536972
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of the immunosuppressive macrolides rapamycin and FK 506 in high responder rats presensitized to major histocompatibility complex antigens.
    Propper DJ; Woo J; Macleod AM; Catto GR; Thomson AW
    Transplant Proc; 1993 Feb; 25(1 Pt 1):673-4. PubMed ID: 7679837
    [No Abstract]   [Full Text] [Related]  

  • 19. Beneficial effect of 15-deoxyspergualin on accelerated rejection in rat heart transplantation.
    Ueda H; Itoh S; Kusaka M; Isurugi K
    Transplant Proc; 1995 Feb; 27(1):420-2. PubMed ID: 7879046
    [No Abstract]   [Full Text] [Related]  

  • 20. Abrogation by rapamycin of accelerated rejection in sensitized rats by inhibition of alloantibody responses and selective suppression of intragraft mononuclear and endothelial cell activation, cytokine production, and cell adhesion.
    Schmidbauer G; Hancock WW; Wasowska B; Badger AM; Kupiec-Weglinski JW
    Transplantation; 1994 Mar; 57(6):933-41. PubMed ID: 8154043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.